News releases

ALL

Jun 28, 2018 corporate

corporate

Notice Regarding Start of Discussions about KYOUEI DRUG WHOLESALERS CO., LTD. Becoming a Wholly Owned Subsidiary of TOHO HOLDINGS CO., LTD.(157 KB)
Jun 28, 2018 corporate

corporate

Notice Regarding Intragroup Reorganization of Seven Pharmaceutical Wholesale Subsidiaries(116 KB)
Jun 15, 2018 product/service

product/service

Notice Regarding Launch of 1 Ingredient/ 2 Products of Generic Drugs for KYOSOMIRAI PHARMA(61 KB)
Jun 12, 2018 M&A/partnership

M&A/partnership

Notice of Conclusion of Business Alliance in Malaysia, Indonesia and Japan with Pharmaniaga(71 KB)
May 09, 2018 performance

performance

Summary of Consolidated Financial Results of Fiscal Year Ended March 31, 2018(355 KB)
May 09, 2018 stock

stock

Announcement about the Adjustment of the Conversion Value for Euro-Yen Denominated Convertible Bonds Maturing in 2019(13 KB)
Apr 27, 2018 performance

performance

Notice of the Revision of the Earnings Forecasts for the Fiscal Year Ended March 2018(40 KB)
Apr 18, 2018 M&A/partnership

M&A/partnership

Announcement about Capital Alliance with AMBICION Co., Ltd.(16 KB)
Mar 23, 2018 product/service

product/service

Notice Regarding Launch of 2 Ingredients/ 5 Products of Generic Drugs for KYOSOMIRAI PHARMA(126 KB)
Mar 19, 2018 M&A/partnership

M&A/partnership

Announcement about Capital Alliance with HekaBio K.K.(29 KB)
Mar 01, 2018 product/service

product/service

Notice Regarding Launch of 1 Ingredient / 2 Products of Generic Drugs for KYOSOMIRAI PHARMA(126 KB)
Feb 15, 2018 product/service

product/service

Notice Regarding Manufacture and Sales Approval of 1 Ingredient / 2 Products of Generic Drugs for KYOSOMIRAI PHARMA(145 KB)
Feb 01, 2018 performance

performance

Results of Operations during the Third Quarter of Fiscal Year Ending March 31, 2018(111 KB)
Dec 08, 2017 product/service

product/service

Notice Regarding Launch of 6 Ingredients/ 14 Products of Generic Drugs for KYOSOMIRAI PHARMA(130 KB)